Another way for melatonin to intervene in the pathogenesis of NAFLD is by inhibiting the nuclear orphan receptor subfamily 4 group A member 1 (NR4A1) in hepatocytes [68]. Here, NR4A1 is linked to metabolic dysfunction-associated steatotic liver disease.